Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells

Circulation Journal

Volumn 73, Issue 1, 2009, Pages 162-166

  Ohshima, Mako ^a   Li, Tao Sheng ^a   Kubo, Masayuki ^a   Qin, Shu Lan ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Oxidative stress; Reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETIC ACID DERIVATIVE; ANTIOXIDANT; CD34 ANTIGEN; GLUCOSE; MANGANESE TETRAKIS 4 BENZOIC ACID PORPHYRIN CHLORIDE; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULAR ENDOTHELIAL CADHERIN 7; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CELL COUNT; CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL STEM CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HEMATOPOIETIC STEM CELL; MALE; MONONUCLEAR CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; OXIDATIVE STRESS; URINE LEVEL;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HEMATOPOIETIC STEM CELLS; MALE; METALLOPORPHYRINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 58549102326     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0123     Document Type: Article

References (32)

1. Hamano K, Li TS, Kobayashi T, Hirata K, Yano M, Kohno M, et al. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg 2002; 73: 1210-1215.
2. Hamano K, Li TS, Kobayashi T, Tanaka N, Kobayashi S, Matsuzaki M, et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: A novel and simple therapeutic method. Surgery 2001; 130: 44-54.
3. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395-1402.
4. Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 2002; 11: 747-752.
5. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, Baffour R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 2003; 41: 1721-1724.
6. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: Clinical trial and preliminary results. Jpn Circ J 2001; 65: 845-847.
7. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-1209.
8. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
9. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
10. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
11. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71: 196-201.
12. Choi JH, Choi J, Lee WS, Rhee I, Lee SC, Gwon HC, et al. Lack of additional benefit of intracoronary transplantation of autologous blood stem cell in patients with acute myocardial infarction. Circ J 2007; 71: 486-494.
13. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615-1622.
14. Li TS, Furutani A, Takahashi M, Ohshima M, Qin SL, Kobayashi T, et al. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 2006; 290: H1362-H1369.
15. Shimada T, Takeshita Y, Murohara T, Sasaki K, Egami K, Shintani S, et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004; 110: 1148-1155.
16. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, et al. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment Am J Pathol 2004; 164: 57-66.
17. Ebrahimian TG, Hermes C, You D, Brude OB, Mees B, Waeckel L, et al. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 2006; 169: 719-728.
18. Cai S, Khoo J, Mussa S, Alp NJ, Channon KM. Endothelial nitric oxide synthase dysfunction in diabetic mice: Importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 2005; 48: 1933-1940.
19. Dembach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress. Blood 2004; 104: 3591-3597.
20. Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 2006; 116: 1071-1080.
21. Wautier JL, Schmidt AM. Protein glycation: A firm link to endothelial cell dysfunction. Circ Res 2004; 95: 233-238.
22. Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 2002; 45: 420-426.
23. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004; 24: 2021-2027.
24. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsuyama T, Yorek Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790.
25. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
26. Kubo M, Li TS, Suzuki R, Ohshima M, Qin SL, Hamano K. Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis. Am J Physiol Heart Circ Physiol 2007; 292: H2582-H2588.
27. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310-1318.
28. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urich C, et al. Erythropoietin is a potent physiologic stimulus for endothelial cell mobilization. Blood 2003; 102: 1340-1346.
29. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006; 12: 446-451.
30. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlirofluorescein assay using microplate reader. Free Radic Biol Med 1999; 27: 612-616.
31. Wallez Y, Vilgrain I, Huber P. Angiogenesis; the VE-cadherin swich. Trends Cardiovasc Med 2006; 16: 55-59.
32. Rask-Madsen C, King GL. Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3: 46-56.